Windtree Retained Earnings from 2010 to 2024

WINT Stock

USD 0.50 0.01 1.96%

Windtree Therapeutics Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that Windtree Therapeutics retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

1995-03-31

Previous Quarter

-834.6 M

Current Value

-846.6 M

Quarterly Volatility

279.3 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Windtree Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windtree Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 77.9 K, Interest Expense of 47.5 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 633, Dividend Yield of 0.0 or PTB Ratio of 0.8. Windtree financial statements analysis is a perfect complement when working with Windtree Therapeutics Valuation or Volatility modules.

Check out the analysis of Windtree Therapeutics Correlation against competitors.

For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Latest Windtree Therapeutics' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Windtree Therapeutics over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Windtree Therapeutics' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Windtree Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (844.82 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Windtree Retained Earnings Regression Statistics

	Arithmetic Mean	(599,706,057)
	Coefficient Of Variation	(36.01)
	Mean Deviation	156,819,379
	Median	(637,114,000)
	Standard Deviation	215,926,428
	Sample Variance	46624.2T
	Range	838M
	R-Value	(0.91)
	Mean Square Error	8935.7T
	R-Squared	0.82
	Slope	(43,775,996)
	Total Sum of Squares	652739.1T

Windtree Retained Earnings History

	2024	-802.6 M
	2023	-844.8 M
	2022	-824.5 M
	2021	-785.3 M
	2020	-717.7 M
	2019	-685.1 M
	2018	-657.6 M

Other Fundumenentals of Windtree Therapeutics

Retained Earnings Total Equity

Windtree Therapeutics Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Long Term Debt	Treasury Stock	Property Plant Equipment	Net Receivables	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Good Will	Capital Stock	Intangible Assets
Total Assets		0.96	-0.46	-0.36	0.21	0.73	0.45	-0.26	-0.32	-0.17	0.0	-0.34	-0.06	0.29	0.33	0.18	0.49	-0.47	0.57	0.84	0.69	0.18	0.11	0.09
Total Stockholder Equity	0.96		-0.59	-0.15	0.07	0.52	0.5	-0.44	-0.15	-0.15	-0.16	-0.18	-0.04	0.08	0.41	0.02	0.34	-0.43	0.49	0.77	0.63	0.26	0.18	0.13
Net Debt	-0.46	-0.59		-0.23	0.1	-0.03	-0.91	0.51	0.11	-0.12	-0.1	0.17	-0.04	0.12	-0.65	-0.13	0.24	-0.07	0.21	0.02	0.03	-0.41	-0.35	-0.27
Retained Earnings	-0.36	-0.15	-0.23		-0.13	-0.64	0.14	-0.11	0.76	-0.08	-0.02	0.71	-0.51	-0.9	0.26	-0.05	-0.86	0.61	-0.71	-0.47	-0.6	0.53	0.55	0.62
Accounts Payable	0.21	0.07	0.1	-0.13		0.55	0.13	0.44	-0.34	0.21	0.58	-0.37	-0.57	0.28	0.16	0.6	0.04	0.41	-0.14	0.14	-0.12	0.37	0.43	0.45
Total Liab	0.73	0.52	-0.03	-0.64	0.55		0.22	0.31	-0.59	-0.11	0.46	-0.6	-0.12	0.61	0.03	0.57	0.66	-0.29	0.49	0.67	0.52	0.12	0.06	0.04
Total Current Assets	0.45	0.5	-0.91	0.14	0.13	0.22		-0.3	-0.22	0.04	0.46	-0.26	-0.12	0.04	0.73	0.45	-0.19	0.17	-0.28	-0.1	-0.17	0.38	0.37	0.33
Short Term Debt	-0.26	-0.44	0.51	-0.11	0.44	0.31	-0.3		-0.14	0.04	0.52	-0.16	-0.37	0.15	-0.35	0.46	0.01	0.37	-0.21	-0.11	-0.21	0.21	0.2	0.23
Common Stock	-0.32	-0.15	0.11	0.76	-0.34	-0.59	-0.22	-0.14		-0.57	-0.26	0.99	-0.32	-0.94	-0.01	-0.28	-0.43	0.23	-0.25	-0.21	-0.23	0.14	0.15	0.16
Current Deferred Revenue	-0.17	-0.15	-0.12	-0.08	0.21	-0.11	0.04	0.04	-0.57		-0.07	-0.59	0.14	0.37	0.03	-0.1	-0.27	0.3	-0.27	-0.22	-0.24	0.15	0.16	0.17
Long Term Debt	0.0	-0.16	-0.1	-0.02	0.58	0.46	0.46	0.52	-0.26	-0.07		-0.3	-0.47	0.22	0.23	0.92	-0.13	0.44	-0.45	-0.28	-0.43	0.35	0.39	0.42
Treasury Stock	-0.34	-0.18	0.17	0.71	-0.37	-0.6	-0.26	-0.16	0.99	-0.59	-0.3		-0.27	-0.9	-0.03	-0.32	-0.37	0.19	-0.2	-0.21	-0.21	0.04	0.07	0.08
Property Plant Equipment	-0.06	-0.04	-0.04	-0.51	-0.57	-0.12	-0.12	-0.37	-0.32	0.14	-0.47	-0.27		0.35	-0.11	-0.58	0.44	-0.51	0.5	0.04	0.37	-0.57	-0.69	-0.85
Net Receivables	0.29	0.08	0.12	-0.9	0.28	0.61	0.04	0.15	-0.94	0.37	0.22	-0.9	0.35		-0.11	0.24	0.6	-0.41	0.42	0.27	0.32	-0.38	-0.34	-0.35
Net Tangible Assets	0.33	0.41	-0.65	0.26	0.16	0.03	0.73	-0.35	-0.01	0.03	0.23	-0.03	-0.11	-0.11		0.14	-0.26	0.15	-0.17	-0.07	-0.25	0.16	0.21	0.2
Long Term Debt Total	0.18	0.02	-0.13	-0.05	0.6	0.57	0.45	0.46	-0.28	-0.1	0.92	-0.32	-0.58	0.24	0.14		-0.04	0.33	-0.34	-0.08	-0.24	0.39	0.51	0.47
Capital Surpluse	0.49	0.34	0.24	-0.86	0.04	0.66	-0.19	0.01	-0.43	-0.27	-0.13	-0.37	0.44	0.6	-0.26	-0.04		-0.72	0.9	0.68	0.78	-0.49	-0.54	-0.64
Short Long Term Debt	-0.47	-0.43	-0.07	0.61	0.41	-0.29	0.17	0.37	0.23	0.3	0.44	0.19	-0.51	-0.41	0.15	0.33	-0.72		-0.81	-0.63	-0.75	0.49	0.52	0.58
Deferred Long Term Liab	0.57	0.49	0.21	-0.71	-0.14	0.49	-0.28	-0.21	-0.25	-0.27	-0.45	-0.2	0.5	0.42	-0.17	-0.34	0.9	-0.81		0.81	0.89	-0.51	-0.56	-0.66
Net Invested Capital	0.84	0.77	0.02	-0.47	0.14	0.67	-0.1	-0.11	-0.21	-0.22	-0.28	-0.21	0.04	0.27	-0.07	-0.08	0.68	-0.63	0.81		0.9	0.01	-0.06	-0.13
Net Working Capital	0.69	0.63	0.03	-0.6	-0.12	0.52	-0.17	-0.21	-0.23	-0.24	-0.43	-0.21	0.37	0.32	-0.25	-0.24	0.78	-0.75	0.89	0.9		-0.17	-0.25	-0.45
Good Will	0.18	0.26	-0.41	0.53	0.37	0.12	0.38	0.21	0.14	0.15	0.35	0.04	-0.57	-0.38	0.16	0.39	-0.49	0.49	-0.51	0.01	-0.17		0.9	0.82
Capital Stock	0.11	0.18	-0.35	0.55	0.43	0.06	0.37	0.2	0.15	0.16	0.39	0.07	-0.69	-0.34	0.21	0.51	-0.54	0.52	-0.56	-0.06	-0.25	0.9		0.8
Intangible Assets	0.09	0.13	-0.27	0.62	0.45	0.04	0.33	0.23	0.16	0.17	0.42	0.08	-0.85	-0.35	0.2	0.47	-0.64	0.58	-0.66	-0.13	-0.45	0.82	0.8

Click cells to compare fundamentals

About Windtree Therapeutics Financial Statements

Windtree Therapeutics shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although Windtree Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Windtree Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Windtree Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-844.8 M	-802.6 M
Retained Earnings Total Equity	-645.9 M	-678.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC